Skip to content
2000
Volume 4, Issue 1
  • ISSN: 2666-7797
  • E-ISSN: 2666-7800

Abstract

The numerous medicinal benefits of cannabis-derived chemicals have attracted a lot of interest in their inclusion into cosmeceuticals. Due to their strong anti-inflammatory, antioxidant, and antibacterial properties, cannabinoids, like Tetrahydrocannabinol (THC) and Cannabidiol (CBD), are excellent options for treating a range of skin issues, such as aging, psoriasis, acne, and eczema. With an emphasis on their interactions with the endocannabinoid system and their capacity to regulate skin homeostasis, this study investigates the mechanisms behind the skin advantages of chemicals produced from cannabis. Furthermore, developments in formulation technologies such as emulsions and nanocarriers are emphasized for improving the stability and bioavailability of these substances in topical applications. To give a thorough grasp of their position in cosmeceuticals, regulatory issues, safety concerns, and the rising demand for plant-based, sustainable skincare products are also covered. In order to highlight the medicinal potential of chemicals produced from cannabis and open the door for creative and effective skincare products, this article will provide an overview of current research and new trends.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cosci/10.2174/0126667797337107250211101229
2025-02-24
2025-10-26

  • From This Site

    /content/journals/cosci/10.2174/0126667797337107250211101229
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. BaswanS.M. KlosnerA.E. GlynnK. RajgopalA. MalikK. YimS. SternN. Therapeutic potential of cannabidiol (CBD) for skin health and disorders.Clin. Cosmet. Investig. Dermatol.20201392794210.2147/CCID.S286411 33335413
     [Google Scholar]
  2. GęgotekA. BiernackiM. AmbrożewiczE. SurażyńskiA. WrońskiA. SkrzydlewskaE. The cross-talk between electrophiles, antioxidant defence and the endocannabinoid system in fibroblasts and keratinocytes after UVA and UVB irradiation.J. Dermatol. Sci.201681210711710.1016/j.jdermsci.2015.11.005 26674123
     [Google Scholar]
  3. FerreiraB.P. CostaG. Mascarenhas-MeloF. PiresP.C. HeidarizadehF. GiramP.S. MazzolaP.G. CabralC. VeigaF. Paiva-SantosA.C. Skin applications of cannabidiol: Sources, effects, delivery systems, marketed formulations and safety.Phytochem. Rev.202322378182810.1007/s11101‑023‑09860‑5
     [Google Scholar]
  4. AndradeC.M.L. CaetanoT.T.V. CamposF.K. GandraV.M. AlvesF.H.F. SteinV.C. Cannabis sativa L. in the cosmeceutical industry: Prospects and biotechnological approaches for metabolite improvement.S. Afr. J. Bot.202316117117910.1016/j.sajb.2023.08.008
     [Google Scholar]
  5. MartinJ.H. SchneiderJ. LucasC.J. GalettisP. Exogenous cannabinoid efficacy: Merely a pharmacokinetic interaction?Clin. Pharmacokinet.201857553954510.1007/s40262‑017‑0599‑0 28921125
     [Google Scholar]
  6. WalshK.B. McKinneyA.E. HolmesA.E. Minor cannabinoids: Biosynthesis, molecular pharmacology and potential therapeutic uses.Front. Pharmacol.20211277780410.3389/fphar.2021.777804 34916950
     [Google Scholar]
  7. SheriffT. LinM.J. DubinD. KhorasaniH. The potential role of cannabinoids in dermatology.J. Dermatolog. Treat.202031883984510.1080/09546634.2019.1675854 31599175
     [Google Scholar]
  8. ChowR. ValdezC. ChowN. ZhangD. ImJ. SodhiE. LockM. Oral cannabinoid for the prophylaxis of chemotherapy-induced nausea and vomiting—a systematic review and meta-analysis.Support. Care Cancer20202852095210310.1007/s00520‑019‑05280‑4 31916006
     [Google Scholar]
  9. JhawarN. SchoenbergE. WangJ.V. SaediN. The growing trend of cannabidiol in skincare products.Clin. Dermatol.201937327928110.1016/j.clindermatol.2018.11.002 31178109
     [Google Scholar]
  10. BadowskiM.E. A review of oral cannabinoids and medical marijuana for the treatment of chemotherapy-induced nausea and vomiting: A focus on pharmacokinetic variability and pharmacodynamics.Cancer Chemother. Pharmacol.201780344144910.1007/s00280‑017‑3387‑5 28780725
     [Google Scholar]
  11. BloemendalV.R.L.J. HestJ.C.M. RutjesF.P.J.T. Synthetic pathways to tetrahydrocannabinol (THC): An overview.Org. Biomol. Chem.202018173203321510.1039/D0OB00464B 32259175
     [Google Scholar]
  12. AzorínC. BenedéJ.L. ChisvertA. SalvadorA. Trace determination of tetrahydrocannabinol (THC) in cosmetic products by stir bar sorptive dispersive microextraction followed by liquid chromatography-tandem mass spectrometry.Talanta202325312393410.1016/j.talanta.2022.123934 36152610
     [Google Scholar]
  13. LiuY. WangY. HaoZ. PanL. HPLC method for separation of cannabidiol hemp seed oil with skin lipids and tandem hrms technology for characterization of a chemical marker.Cosmetics20218410810.3390/cosmetics8040108
     [Google Scholar]
  14. MasyitaA. SariM.R. AstutiD.A. YasirB. RumataR.N. EmranT.B. NainuF. Simal-GandaraJ. Terpenes and terpenoids as main bioactive compounds of essential oils, their roles in human health and potential application as natural food preservatives.Food Chem. X20221310021710.1016/j.fochx.2022.100217 35498985
     [Google Scholar]
  15. YangW ChenX LiY GuoS WangZ YuX. Advances in pharmacological activities of terpenoids. Nat. Prod. Commun.,20201531934578X2090355510.1177/1934578X20903555
     [Google Scholar]
  16. GaoniY. MechoulamR. Isolation, structure, and partial synthesis of an active constituent of hashish.J. Am. Chem. Soc.19648681646164710.1021/ja01062a046
     [Google Scholar]
  17. PaulR. WilliamsR. HodsonV. PeakeC. Detection of cannabinoids in hair after cosmetic application of hemp oil.Sci. Rep.201991258210.1038/s41598‑019‑39609‑0 30796346
     [Google Scholar]
  18. NoriegaP. .Terpenes in essential oils: Bioactivity and applications. Terp. Terp. Rec. Adv.,20211610.5772/intechopen.93792
  19. ZamoraP.C. TorresC. NuñezM. Antimicrobial activity and chemical composition of essential oils from verbenaceae species growing in south america.Molecules201823354410.3390/molecules23030544 29494478
     [Google Scholar]
  20. FlaminiG. CioniP.L. PuleioR. MorelliI. PanizziL. Antimicrobial activity of the essential oil of Calamintha nepeta and its constituent pulegone against bacteria and fungi.Phytother. Res.199913434935110.1002/(SICI)1099‑1573(199906)13:4<349:AID‑PTR446>3.0.CO;2‑Z 10404547
     [Google Scholar]
  21. AtalayS. Jarocka-KarpowiczI. SkrzydlewskaE. antioxidative and anti-inflammatory properties of cannabidiol.Antioxidants2019912110.3390/antiox9010021 31881765
     [Google Scholar]
  22. BhavaniramyaS. VishnupriyaS. Al-AboodyM.S. VijayakumarR. BaskaranD. Role of essential oils in food safety: Antimicrobial and antioxidant applications.Grain Oil Sci. Tech.201922495510.1016/j.gaost.2019.03.001
     [Google Scholar]
  23. AljaafariM.N. AlAliA.O. BaqaisL. AlqubaisyM. AlAliM. MoloukiA. Ong-AbdullahJ. AbushelaibiA. LaiK.S. LimS.H.E. An overview of the potential therapeutic applications of essential oils.Molecules202126362810.3390/molecules26030628 33530290
     [Google Scholar]
  24. PetrovićJ. StojkovićD. SokovićM. Terpene core in selected aromatic and edible plants: Natural health improving agents.Adv. Food Nutr. Res.20199042345110.1016/bs.afnr.2019.02.009 31445600
     [Google Scholar]
  25. BursteinS. Cannabidiol (CBD) and its analogs: A review of their effects on inflammation.Bioorg. Med. Chem.20152371377138510.1016/j.bmc.2015.01.059 25703248
     [Google Scholar]
  26. RajanT.S. GiacoppoS. IoriR. NicolaD.G.R. GrassiG. PollastroF. BramantiP. MazzonE. Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages.Fitoterapia201611210411510.1016/j.fitote.2016.05.008 27215129
     [Google Scholar]
  27. KopustinskieneD.M. MasteikovaR. LazauskasR. BernatonieneJ. Cannabis sativa L. bioactive compounds and their protective role in oxidative stress and inflammation.Antioxidants202211466010.3390/antiox11040660 35453344
     [Google Scholar]
  28. PeyravianN. DeoS. DaunertS. JimenezJ.J. The anti-inflammatory effects of cannabidiol (CBD) on acne.J. Inflamm. Res.2022152795280110.2147/JIR.S355489 35535052
     [Google Scholar]
  29. RathiS. Acne vulgaris treatment: The current scenario.Indian J. Dermatol.201156171310.4103/0019‑5154.77543 21572783
     [Google Scholar]
  30. FerreiraI. LopesC.M. AmaralM.H. Treatment advances for acne vulgaris: The scientific role of cannabinoids.Cosmetics20241112210.3390/cosmetics11010022
     [Google Scholar]
  31. WrońskiA. Jarocka-KarpowiczI. StasiewiczA. SkrzydlewskaE. Phytocannabinoids in the pharmacotherapy of psoriasis.Molecules2023283119210.3390/molecules28031192 36770858
     [Google Scholar]
  32. EaglestonL.R.M. KalaniN.K. PatelR.R. FlatenH.K. DunnickC.A. DellavalleR.P. Cannabinoids in dermatology: A scoping review. Dermatol. Online J.,201824613030/qt7pn8c0sb10.5070/D3246040706 30142706
     [Google Scholar]
  33. MartinsA.M. GomesA.L. BoasV.I. MartoJ. RibeiroH.M. Cannabis-based products for the treatment of skin inflammatory diseases: A timely review.Pharmaceuticals202215221010.3390/ph15020210 35215320
     [Google Scholar]
  34. GerasymchukM. RobinsonG.I. GrovesA. HaselhorstL. NandakumarS. StahlC. KovalchukO. KovalchukI. Phytocannabinoids stimulate rejuvenation and prevent cellular senescence in human dermal fibroblasts.Cells20221123393910.3390/cells11233939 36497198
     [Google Scholar]
  35. FrancoC. ProttiS. PortaA. PollastroF. ProfumoA. MannucciB. MerliD. Stability of cannabidiol (CBD) in solvents and formulations: A GC–MS approach.Results Chem.2022410046510.1016/j.rechem.2022.100465
     [Google Scholar]
  36. KosovićE. SýkoraD. KuchařM. Stability study of cannabidiol in the form of solid powder and sunflower oil solution.Pharmaceutics202113341210.3390/pharmaceutics13030412 33808893
     [Google Scholar]
  37. YooE.H. LeeJ.H. Cannabinoids and their receptors in skin diseases.Int. J. Mol. Sci.202324221652310.3390/ijms242216523 38003712
     [Google Scholar]
  38. CooperZ.D. AbramsD.I. GustS. SalicrupA. ThrockmortonD.C. Challenges for clinical cannabis and cannabinoid research in the united states.J. Natl. Cancer Inst. Monogr.202120215811412210.1093/jncimonographs/lgab009 34850896
     [Google Scholar]
  39. PalrasuM. WrightL. PatelM. LeechL. BranchS. HarrelsonS. KhanS. Perspectives on challenges in cannabis drug delivery systems: Where are we?Med. Cannab. Cannab.20225110211910.1159/000525629 36467783
     [Google Scholar]
  40. BruniN. PepaD.C. Oliaro-BossoS. GastaldiD. DosioF. PessioneE. Recent Cannabinoid Delivery Systems.Cannabis as Medicine; CRC Press: Bara Boca,201912916010.1201/9780429054723‑12
  41. Zagórska-DziokM. BujakT. ZiemlewskaA. Nizioł-ŁukaszewskaZ. Positive effect of Cannabis sativa l. herb extracts on skin cells and assessment of cannabinoid-based hydrogels properties.Molecules202126480210.3390/molecules26040802 33557174
     [Google Scholar]
  42. KirkR.D. AkanjiT. LiH. ShenJ. AllababidiS. SeeramN.P. BertinM.J. MaH. Evaluations of skin permeability of cannabidiol and its topical formulations by skin membrane-based parallel artificial membrane permeability assay and franz cell diffusion assay.Med. Cannabis Cannabinoids20225112913710.1159/000526769 36467778
     [Google Scholar]
  43. StellaB. BarattaF. PepaD.C. ArpiccoS. GastaldiD. DosioF. Cannabinoid formulations and delivery systems: Current and future options to treat pain.Drugs202181131513155710.1007/s40265‑021‑01579‑x 34480749
     [Google Scholar]
  44. FilipiucS.I. NeaguA.N. UrituC.M. TambaB.I. FilipiucL.E. TudoranceaI.M. BocaA.N. HâncuM.F. PorumbV. BildW. The skin and natural cannabinoids–topical and transdermal applications.Pharmaceuticals2023167104910.3390/ph16071049 37513960
     [Google Scholar]
  45. BruniN. PepaD.C. Oliaro-BossoS. PessioneE. GastaldiD. DosioF. Cannabinoid delivery systems for pain and inflammation treatment.Molecules20182310247810.3390/molecules23102478 30262735
     [Google Scholar]
  46. MeadA. The legal status of Cannabis (marijuana) and cannabidiol (CBD) under U.S. law. Epilepsy. Behav.,201770(Pt B)28829110.1016/j.yebeh.2016.11.021 28169144
  47. ChenC. PanZ. Cannabidiol and terpenes from hemp – ingredients for future foods and processing technologies.Journal of Future Foods20211211312710.1016/j.jfutfo.2022.01.001
     [Google Scholar]
  48. NayakP. PantvaidyaG. RanganathanP. JiwnaniS. JoshiS. GogtayN.J. Clinical studies with Cannabis in India – A need for guidelines for the investigators and ethics committees.Perspect. Clin. Res.202314314615110.4103/picr.picr_159_22 37554245
     [Google Scholar]
  49. LiJ. CarvajalR. BrunerL. KaminskiN.E. The current understanding of the benefits, safety, and regulation of cannabidiol in consumer products.Food Chem. Toxicol.202115711260010.1016/j.fct.2021.112600 34626752
     [Google Scholar]
  50. RussoE.B. Cannabidiol claims and misconceptions.Trends Pharmacol. Sci.201738319820110.1016/j.tips.2016.12.004 28089139
     [Google Scholar]
  51. TijaniA.O. ThakurD. MishraD. FrempongD. ChukwunyereU.I. PuriA. Delivering therapeutic cannabinoids via skin: Current state and future perspectives.J. Control. Release202133442745110.1016/j.jconrel.2021.05.005 33964365
     [Google Scholar]
  52. BowenJ.K. ChaparroJ.M. McCorkleA.M. PalumboE. PrenniJ.E. The impact of extraction protocol on the chemical profile of cannabis extracts from a single cultivar.Sci. Rep.20211112180110.1038/s41598‑021‑01378‑0 34750475
     [Google Scholar]
  53. PeschelW. Quality control of traditional cannabis tinctures: Pattern, markers, and stability.Sci. Pharm.201684356758410.3390/scipharm84030567 28117322
     [Google Scholar]
  54. RousseauxC.G. SchachterH. Regulatory issues concerning the safety, efficacy and quality of herbal remedies.Birth Defects Res. B Dev. Reprod. Toxicol.200368650551010.1002/bdrb.10053 14745988
     [Google Scholar]
  55. WileyJ.L. GourdetC.K. ThomasB.F. F Cannabidiol: Science, Marketing, and Legal Perspectives; Research Triangle Park, NC: Raleigh, Durham,202010.3768/rtipress.2020.op.0065.2004
     [Google Scholar]
  56. WaltonA.L. KellisK. TankersleyW.E. PatelR.S. Cultivating Evidence‐Based pathways for cannabis product development: Implications for consumer protection †.Am. Bus. Law. J.202057477382510.1111/ablj.12173
     [Google Scholar]
  57. RibeiroN.G. AñañaE.S. BarbosaB. The influence of human values, environmental awareness, and attitudes on the intention to purchase cannabis-based skincare cosmetics.Sustainability202214161039910.3390/su141610399
     [Google Scholar]
  58. MakhakheL. Topical cannabidiol (CBD) in skin pathology – A comprehensive review and prospects for new therapeutic opportunities.S. Afr. Fam. Pract.202264110.4102/safp.v64i1.5493
     [Google Scholar]
  59. ErridgeS. CoomberR. SodergrenM.H. Medical cannabis, CBD wellness products and public awareness of evolving regulations in the United Kingdom.Journal of Cannabis Research2022415610.1186/s42238‑022‑00165‑6 36309761
     [Google Scholar]
  60. KhalidS. AlmalkiF.A. HaddaT.B. BaderA. Abu-IzneidT. BerredjemM. ElsharkawyE.R. AlqahtaniA.M. Medicinal applications of cannabinoids extracted from Cannabis sativa (L.): A new route in the fight against COVID-19?Curr. Pharm. Des.202127131564157810.2174/1381612826666201202125807 33267756
     [Google Scholar]
  61. PisantiS. BifulcoM. Medical Cannabis: A plurimillennial history of an evergreen.J. Cell. Physiol.201923468342835110.1002/jcp.27725 30417354
     [Google Scholar]
  62. MnekinL. RipollL. Topical use of Cannabis sativa L. biochemicals.Cosmetics2021838510.3390/cosmetics8030085
     [Google Scholar]
  63. LiuY. LiuH.Y. LiS.H. MaW. WuD.T. LiH.B. XiaoA-P. LiuL-L. ZhuF. GanR-Y. Cannabis sativa bioactive compounds and their extraction, separation, purification, and identification technologies: An updated review.Trends Analyt. Chem.202214911655410.1016/j.trac.2022.116554
     [Google Scholar]
  64. ParkJ. LeH.T.P.M. AmendahE.R. KimD. A look at collaborative service provision: Case for cosmetic surgery medical tourism at korea for chinese patients.Int. J. Environ. Res. Public Health202118241332910.3390/ijerph182413329 34948934
     [Google Scholar]
  65. CraddockN. SpotswoodF. RumseyN. DiedrichsP.C. “We should educate the public that cosmetic procedures are as safe as normal medicine”: Understanding corporate social responsibility from the perspective of the cosmetic procedures industry.Body Image202243758610.1016/j.bodyim.2022.08.011 36063763
     [Google Scholar]
  66. TkaczykA. MitrowskaK. PosyniakA. Synthetic organic dyes as contaminants of the aquatic environment and their implications for ecosystems: A review.Sci. Total Environ.202071713722210.1016/j.scitotenv.2020.137222 32084689
     [Google Scholar]
  67. DarbreP.D. Cosmeceuticals. Personal Care Products and Human Health.New YorkElsevier2023799510.1016/B978‑0‑323‑99684‑6.00007‑0
     [Google Scholar]
  68. DasS. DasS. DasM.K. Nanocosmeceuticals: Concept, opportunities, and challenges. Nanocosmeceuticals.New YorkElsevier2022316910.1016/B978‑0‑323‑91077‑4.00008‑9
     [Google Scholar]
  69. BiswasN.G. DasM.K. Introduction to nanotechnology in personal care products. Nanocosmeceuticals.New YorkElsevier202232910.1016/B978‑0‑323‑91077‑4.00007‑7
     [Google Scholar]
  70. GonçalvesJ. RosadoT. SoaresS. SimãoA.Y. CarameloD. LuísÂ. FernándezN. BarrosoM. GallardoE. DuarteA.P. Cannabis and its secondary metabolites: Their use as therapeutic drugs, toxicological aspects, and analytical determination.Medicines2019613110.3390/medicines6010031 30813390
     [Google Scholar]
  71. SchanknechtE. BachariA. NassarN. PivaT. MantriN. Phytochemical constituents and derivatives of cannabis sativa; bridging the gap in melanoma treatment.Int. J. Mol. Sci.202324185910.3390/ijms24010859 36614303
     [Google Scholar]
  72. HallW. StjepanovićD. DawsonD. LeungJ. The implementation and public health impacts of cannabis legalization in Canada: A systematic review.Addiction2023118112062207210.1111/add.16274 37380613
     [Google Scholar]
  73. GorelickD.A. Cannabis-related disorders and toxic effects.N. Engl. J. Med.2023389242267227510.1056/NEJMra2212152 38091532
     [Google Scholar]
  74. ImtiazS. NigatuY.T. AliF. DouglasL. HamiltonH.A. RehmJ. RuedaS. SchwartzR.M. WellsS. Elton-MarshallT. Cannabis legalization and cannabis use, daily cannabis use and cannabis-related problems among adults in Ontario, Canada (2001–2019).Drug Alcohol Depend.202324410976510.1016/j.drugalcdep.2023.109765 36652851
     [Google Scholar]
  75. MyranD.T. PuglieseM. RobertsR.L. SolmiM. PerlmanC.M. FiedorowiczJ. TanuseputroP. AndersonK.K. Association between non-medical Cannabis legalization and emergency department visits for cannabis-induced psychosis.Mol. Psychiatry202328104251426010.1038/s41380‑023‑02185‑x 37500826
     [Google Scholar]
  76. RaihanA. BijoyT.R. A review of the industrial use and global sustainability of Cannabis sativa.Glob. Sustainab. Res.20232412910.56556/gssr.v2i4.597
     [Google Scholar]
  77. FarrellyK.N. WardellJ.D. MarsdenE. ScarfeM.L. NajdzionekP. TurnaJ. MacKillopJ. The impact of recreational cannabis legalization on cannabis use and associated outcomes: A systematic review.Subst. Abuse2023171178221823117205410.1177/11782218231172054 37187466
     [Google Scholar]
  78. ViskovićJ. ZheljazkovV.D. SikoraV. NollerJ. LatkovićD. OcambC.M. KorenA. Industrial hemp (Cannabis sativa L.) agronomy and utilization: A review.Agronomy202313393110.3390/agronomy13030931
     [Google Scholar]
  79. LaphamG.T. MatsonT.E. BobbJ.F. LuceC. OliverM.M. HamiltonL.K. BradleyK.A. Prevalence of cannabis use disorder and reasons for use among adults in a US state where recreational cannabis use is legal.JAMA Netw. Open202368e2328934e232893410.1001/jamanetworkopen.2023.28934 37642968
     [Google Scholar]
  80. SultanR.S. ZhangA.W. OlfsonM. KwizeraM.H. LevinF.R. Nondisordered cannabis use among US adolescents.JAMA Netw. Open202365e2311294e231129410.1001/jamanetworkopen.2023.11294 37133862
     [Google Scholar]
  81. JeffersA.M. GlantzS. ByersA.L. KeyhaniS. Association of Cannabis Use with Cardiovascular outcomes among US adults.J. Am. Heart Assoc.2024135e03017810.1161/JAHA.123.030178 38415581
     [Google Scholar]
  82. GoodwinB.K. Integration of the US cannabis market.Am. J. Agric. Econ.202410.1111/ajae.12488
     [Google Scholar]
/content/journals/cosci/10.2174/0126667797337107250211101229
Loading
Therapeutic Potentials and Applications of Cannabis-Derived Compounds in Cosmeceuticals
Curr. Cosm. Sci. 4, E26667797337107 (2025); https://doi.org/10.2174/0126667797337107250211101229
/content/journals/cosci/10.2174/0126667797337107250211101229
/content/journals/cosci/10.2174/0126667797337107250211101229
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): anti-inflammatory; antioxidant; Cannabinoid; cannabis; cosmeceutical; tetrahydrocannabinol

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test